65LAB (BRIDGE collaboration of A*STAR + NUS + Duke NUS + Evotec et al)

https://www.65lab.sg

65LAB was founded to turn innovations into lifesaving medicines. Our mission is to drive scientific advancement and create new therapeutic companies from Singapore. We accelerate the drug discovery pathway and new company formation by bringing together the expertise of global partners — leading research institutions in Singapore, established life science investors, and reputed drug discovery and development company Evotec. 65 pays homage to the year Singapore became an independent nation. It is also Singapore’s country code. *

	Start	2023-10-05 established jv
	Group	Hebrew University of Jerusalem
	Industry	drug discovery
	Industry 2	translational medicine / translational research
	Person	Hanke, Thomas (Evotec 202104 Head of Academic Partners joined 201311 before Novo Nordisk + TeGenero)
	Person 2	Isacson, Christina (Lightstone Ventures 202306)

	Street	79 Science Park Drive Cintech IV, #04-05
	City	118264 Singapore
		Address record changed: 2024-07-30

Basic data	Employees	n. a.

		* Document for »About Section«: 65LAB. (7/29/24). "Press Release: 65LAB and Duke-NUS Award US$1.85 Million to Combat Chronic Inflammation". Singapore.

		Record changed: 2024-08-24